Inovio Pharmaceuticals (INO) News Today $1.36 -0.03 (-2.16%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$1.38 +0.01 (+1.10%) As of 05:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Rating of "Moderate Buy" by Brokerages3 hours ago | americanbankingnews.comInovio Pharmaceuticals, Inc. (INO) Latest Stock News & Headlines ...July 13 at 7:16 PM | finance.yahoo.comPiper Sandler Initiates Coverage of Inovio Pharmaceuticals (INO) with Overweight RecommendationJuly 10, 2025 | msn.comInovio wins new Overweight at Piper Sandler on potential FDA nod for lead drugJuly 9, 2025 | msn.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Rating of "Moderate Buy" by AnalystsJuly 9, 2025 | marketbeat.comINOVIO Announces Public Offering of Common Stock and WarrantsJuly 7, 2025 | msn.comINOVIO to Present at Upcoming Scientific ConferenceJuly 7, 2025 | prnewswire.comInovio Pharmaceuticals Inc. (INO) Stock Price Today - WSJJuly 3, 2025 | wsj.comInovio Pharmaceuticals Stock Falls After Pricing OfferingJuly 3, 2025 | marketwatch.comINOVIO Announces Pricing of $25 Million Public OfferingJuly 3, 2025 | prnewswire.comInovio Pharmaceuticals (NASDAQ:INO) Stock Price Passes Above 200-Day Moving Average - Should You Sell?July 3, 2025 | marketbeat.comInovio Pharmaceuticals stock plunges after announcing public offeringJuly 2, 2025 | uk.investing.comInovio Pharma Shares Slide on Plans for Public OfferingJuly 2, 2025 | marketwatch.comINOVIO Announces Proposed Public OfferingJuly 2, 2025 | prnewswire.comAvacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business DevelopmentJuly 1, 2025 | globenewswire.comWall Street Zen Upgrades Inovio Pharmaceuticals (NASDAQ:INO) to HoldJune 27, 2025 | marketbeat.comRecurrent Respiratory Papillomatosis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Precigen, Inovio PharmaJune 23, 2025 | theglobeandmail.comInovio Pharmaceuticals (NASDAQ:INO) Will Have To Spend Its Cash WiselyJune 19, 2025 | finance.yahoo.comInovio Pharmaceuticals (NASDAQ:INO) Rating Lowered to Sell at Wall Street ZenJune 14, 2025 | marketbeat.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Position Boosted by Bank of America Corp DEJune 7, 2025 | marketbeat.comInovio shareholders approve board nominees and proposalsMay 24, 2025 | investing.com1,050,000 Shares in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Purchased by Stonepine Capital Management LLCMay 20, 2025 | marketbeat.comOCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes Position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO)May 16, 2025 | marketbeat.comInovio Pharmaceuticals (NASDAQ:INO) Stock Rating Lowered by StockNews.comMay 14, 2025 | marketbeat.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2025 Earnings Call TranscriptMay 14, 2025 | msn.comINOVIO Pharmaceuticals, Inc.: INOVIO Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 14, 2025 | finanznachrichten.deQ1 2025 Inovio Pharmaceuticals Inc Earnings CallMay 14, 2025 | finance.yahoo.comInovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comINOVIO Reports First Quarter 2025 Financial Results and Recent Business HighlightsMay 13, 2025 | prnewswire.comInovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript)May 9, 2025 | seekingalpha.comDeep Track Capital LP Has $5.71 Million Stock Holdings in Inovio Pharmaceuticals, Inc. (NASDAQ:INO)May 9, 2025 | marketbeat.comInovio Pharmaceuticals (INO) to Release Earnings on TuesdayMay 8, 2025 | marketbeat.comINOVIO to Present at Upcoming Scientific and Investor ConferencesApril 30, 2025 | prnewswire.comINOVIO to Report First Quarter 2025 Financial Results on May 13, 2025April 29, 2025 | prnewswire.comShort Interest in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Grows By 19.6%April 22, 2025 | marketbeat.comInovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Rating of "Moderate Buy" from AnalystsApril 21, 2025 | marketbeat.comInovio Pharmaceuticals Inc. stock rises Friday, still underperforms marketApril 11, 2025 | marketwatch.comNext-generation Covid-19 vaccines currently being testedApril 10, 2025 | finance.yahoo.comINOVIO to Present at Upcoming Scientific ConferencesApril 9, 2025 | prnewswire.comINOVIO to Present at Upcoming Scientific ConferencesApril 9, 2025 | prnewswire.comInovio Pharmaceuticals (NASDAQ:INO) Upgraded at StockNews.comMarch 22, 2025 | marketbeat.comHC Wainwright Issues Positive Estimate for INO EarningsMarch 22, 2025 | marketbeat.comInovio Pharmaceuticals (NASDAQ:INO) Price Target Lowered to $5.00 at Royal Bank of CanadaMarch 20, 2025 | marketbeat.comHC Wainwright Reiterates Neutral Rating for Inovio Pharmaceuticals (NASDAQ:INO)March 20, 2025 | marketbeat.comRBC Capital Sticks to Their Hold Rating for Inovio Pharmaceuticals (INO)March 19, 2025 | markets.businessinsider.comInovio price target lowered to $5 from $6 at RBC CapitalMarch 19, 2025 | markets.businessinsider.comInovio reports Q4 EPS (65c), consensus (83c)March 19, 2025 | markets.businessinsider.comInovio price target lowered to $12 from $18 at Citizens JMPMarch 19, 2025 | markets.businessinsider.comInovio aims for INO-3107 regulatory submission by mid-2025 while addressing key manufacturing issuesMarch 19, 2025 | msn.comInovio Pharmaceuticals (NASDAQ:INO) Announces Quarterly Earnings Results, Beats Estimates By $0.23 EPSMarch 19, 2025 | marketbeat.com Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address INO Media Mentions By Week INO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INO News Sentiment▼0.541.01▲Average Medical News Sentiment INO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INO Articles This Week▼93▲INO Articles Average Week Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Moderna News TriSalus Life Sciences News Profound Medical News CVRx News KORU Medical Systems News Electromed News LENSAR News Pro-Dex News Anteris Technologies Global News Avita Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INO) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.